This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit October 30, 2014
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Fall Managed Care Forum
Nov. 13-14, 2014
Bellagio Hotel
Las Vegas Nevada


Click here to visit the conference website.

Click Here to view our Complimentary Online CME/CEU Webcasts

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

 



NAMCP Medical Directors Institute Releases New Dossier Templates
The NAMCP Medical Directors Institute has simultaneously released the NAMCP Medical Technologies Dossier Template and the NAMCP Medical Diagnostics Dossier Template, which provide medical directors and manufacturers with a dossier template formats for either medical devices or diagnostics that accounts for evidence-based development approaches and unique aspects of each of these technology types (instead of having to attempt to follow drug-based formats that are often not ideal for these types of health technologies). NAMCP developed this format at the request of its membership because a consistent format for presenting information about medical devices and diagnostics hasn't been made available to the managed care community.

Please click here to download the templates on our website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Journal of Managed Care Medicine new website released
The Journal of Managed Care Medicine (JMCM) has released its new website at www.jmcmpub.org. The website features current issues, past issues, supplements and much more. Be sure to visit the website for updates on the latest topics in managed care medicine.

If you are interested in advertising on the website or in JMCM, please click here.

If you would like a free subscription to the Journal of Managed Care Medicine, click here and fill out the form.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


GENOMICS


Here's how well your genes can predict your breast cancer risk
TIME
Your genes have a lot to say about who you are and how healthy you are. But for certain diseases, including cancer, so many genes are likely involved that it’s hard for doctors to come up with a useful, reliable way to turn your DNA information into a precise risk score.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Researcher: Study how genes work together
MedPage Today
Science must look at genes and the proteins they express in their full context, not just in isolation, according to an up-and-coming young genetics researcher. "Traits don't exist in silos," said Jennifer Below, Ph.D., of the University of Texas Graduate School of Biomedical Sciences in Houston.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Genes for high LDL-C linked to aortic-valve disease
Medscape
Individuals with a genetic predisposition to high levels of LDL cholesterol are at risk for aortic-valve calcification and aortic stenosis, according to the results of a new study[1]. Using a weighted genetic risk score for lipids, one that incorporated multiple single nucleotide polymorphisms known to be associated with LDL-cholesterol, HDL-cholesterol, and triglyceride levels, the researchers showed that a genetic elevation in LDL cholesterol is associated with the presence of aortic-valve calcification and incident aortic stenosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Predictive analytics seen as future of personalized healthcare
Health Data Management
While health analytics can help improve quality outcomes, increase patient satisfaction and reduce costs, allowing healthcare organizations to draw specific actionable conclusions, they must embrace predictive analytics to realize the promise of personalized care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis
News-Medical.net
InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


REGENERATIVE MEDICINE


Stem cells that release cancer-killing toxins offer new brain tumor treatment
Medical News Today
A new way to to use stem cells to fight brain cancer is revealed in a proof-of-concept study published in the journal Stem Cells, where scientists describe how they got the cells to produce and release toxins that kill only tumor cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Scientists generate first human stomach tissue in lab with stem cells
Medical Xpress
Scientists used pluripotent stem cells to generate functional, three-dimensional human stomach tissue in a laboratory — creating an unprecedented tool for researching the development and diseases of an organ central to several public health crises, ranging from cancer to diabetes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  InSightec - World Leader in MRgFUS

MRgFUS is being used in clinics across America to treat uterine fibroids and pain palliation for metastatic bone tumors. It’s a completely non-invasive procedure performed on an outpatient basis where patients report an improvement in QoL within days, not weeks. Discover InSightec now.
 


EMERGING MEDICAL TECHNOLOGIES


New report tempers rosy outlook for wearable health devices
Forbes
Is all the excitement about wearable digital devices actually worth it? A new report out from PricewaterhouseCoopers examines the state of wearables right now, revealing that fewer than half of people who own such a device actually use it every day. In fact, for all the optimism put forth by producers and regular users of wearable devices — things like fitness bands, Google Glass, and other digital tools worn on the body — they don’t have much to show for it.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Google developing a pill that would detect cancer and other diseases
Wired
Google is attempting to develop a pill that would send microscopic particles into the bloodstream in an effort to identify cancers, imminent heart attacks, and other diseases. Andrew Conrad, the head of life sciences inside the company’s Google X research lab, revealed the project at a conference in Southern California.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA approves 2 faster Ebola tests
The Wall Street Journal via Fox News
The Food and Drug Administration authorized use of two new diagnostic tests for Ebola that can produce results in two hours, compared with what can usually take four hours. The agency said it was giving emergency use approvals to two tests from BioFire Defense LLC, one for use in hospitals and commercial laboratories, the other only in labs designated by the U.S. Department of Defense.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA approves 2 drugs to treat deadly lung disease
The Wall Street Journal
The U.S. Food and Drug Administration approved two new drugs that are the first treatments shown to slow the progression of a fatal lung disease that kills up to 40 percent of patients within five years of diagnosis. The FDA approved the drugs, Roche Holding’s Esbriet and Boehringer Ingelheim GmbH’s Ofev, to treat idiopathic pulmonary fibrosis, or IPF, a condition whose cause is unknown but which is devastating to the roughly 100,000 people in the U.S. who have the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


House calls key to pioneer ACO success
HealthLeaders Media
Placing an emphasis on case management for patients with the most serious conditions and co-morbidities has paid off for two participants in the Pioneer ACO program. Three years after launching its Medicare Accountable Care Organizations program, also known as the Pioneer ACO program, the Centers for Medicare & Medicaid Services has published financial results and quality performance data.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CMS announces new IT investment model for ACOs
Health IT Outcomes
A CMS initiative will help ACOs in rural locations use health IT for better access to care. CMS announced that $114 million dollars in funding will be available to aid ACOs that participate in the Medicare Shared Savings Program. "The ACO Investment Model will give Medicare accountable care organizations more flexibility in setting quality and financial goals, while giving them greater accountability for delivering quality care efficiently," said CMS Administrator Marilyn Tavenner, according to Healthcare IT News.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Choosing a health plan is hard, even for a health economist
The New York Times
Austin Frakt writes: A confession: I am a health economist, and I cannot rationally select a health plan. I buy health insurance through the Federal Employees Health Benefits Program, which is very similar to the Affordable Care Act’s exchanges. Like the exchanges, the federal employee program runs an online marketplace with a choice of plans, which vary by region. Most workers don’t have a lot of choice among plans offered by their employer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


10 ways to apply social tools for an improved patient experience
By Christina Thielst
The pressures and drivers to reduce costs, improve quality, emphasize prevention and increase access are making social media and the underlying technologies more attractive to healthcare leaders. They can be effective and efficient tools for the delivery of communications to targeted individuals and/or populations. As a result, those leaders who recognize that we must change the way care is provided are starting to explore new ways of engaging patients across the continuum of care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"The largest waterborne disease outbreak in United States history occurred in 1993 in Milwaukee when over 400,000 people became ill with diarrhea when the parasite Cryptosporidium was found in the city's drinking water supply."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Massive study reveals schizophrenia's genetic roots (Scientific American)
Whole-gene scan analyzes mystery illnesses in kids (NBC News)
Paralyzed man walks after nose cells placed in spine (Chicago Tribune)
Where genes and genealogies diverge (Forbes)
Why health insurance companies are doomed (Fortune)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Oct. 23, 2014
Oct. 16, 2014
Oct. 9, 2014
Oct. 2, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063